Introducing Silo Tab 50mg – your partner in managing diabetes. These tablets contain Sitagliptin, a DPP-4 inhibitor that helps regulate glucose levels in type 2 diabetes patients. By slowing the inactivation of incretin hormones like GLP-1 and GIP, it boosts insulin release and reduces glucagon secretion, leading to improved glucose control. Silo Tabs are versatile, suitable for monotherapy or in combination with other medications when single-agent treatment isn't enough. They offer effective glycemic control through dual therapy, triple therapy, and even in combination with insulin. Each tablet contains 50mg of sitagliptin, working to enhance glucose homeostasis. Say goodbye to the complexities of diabetes management with Silo, your aid in achieving better glycemic control and a more balanced life.